YAP1 and Alzheimer disease: First, although it has been demonstrated that the expression levels of FGF2 and YAP1 in plasma were upregulated in elderly individuals with MCI, the specific pathways of action and regulatory mechanisms in the pathogenesis of AD still needs to be clarified in the future.